Peterborough, Canada Clinical Trials

A listing of Peterborough, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 72 clinical trials
None
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

This is a study in adults who had a heart attack (myocardial infarction). The purpose of this study is to find out whether a medicine called empagliflozin helps to lower the chances of having to go to the hospital for heart failure and whether it lowers the chances of dying …

myocardial infarction
revascularisation
infarct
cardiovascular disease
st elevation myocardial infarction
Peterborough Regional Health Centre
 (1.5 away) Contact site
  • 44 views
  • 26 Nov, 2021
  • +255 other locations
None
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

The purpose of this study is to evaluate the effect of finerenone compared to placebo (a tablet without active substance) in the reduction of cardiovascular death (generally meaning death due to disease of the heart or blood vessels) and total Heart Failure (HF) events, including HF hospitalization and urgent visits …

ejection fraction
stroke
heart failure
natriuretic peptide
nt-probnp
Kawartha Cardiology Clinical Trials
 (0.6 away) Contact site
  • 37 views
  • 29 Oct, 2021
  • +791 other locations
None
Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo Forte Gel and Vehicle Gel

The safety and efficacy of once daily application of IDP 126 Gel will be compared to Epiduo Forte and IDP-126 Vehicle Gel.

Bausch Site 115
 (0.0 away) Contact site
  • 35 views
  • 24 Jun, 2021
  • +35 other locations
None
An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

This is a clinical study in adult participants with moderate to severe atopic dermatitis (AD). The purpose of the study is to test a new medicine (LEO 138559) given by injection to see if it works to treat AD and what the side effects are when compared with a placebo …

topical agents
eczema
LEO Investigational Site
 (1.9 away) Contact site
  • 4 views
  • 01 Dec, 2021
  • +31 other locations
None
A Study to Evaluate the Safety and Efficacy of PF-06650833 PF-06700841 and PF 06826647 in Adults With Hidradenitis Suppurativa

This is a study with 3 kinase inhibitors (PF 06650833, PF 06700841 and PF 06826647) in participants with moderate to severe HS. The study will have a maximum duration of approximately 26 weeks. This includes an up to 6-week Screening Period, a 16 week Dosing Period and a 4 week …

hidradenitis
SKiN Centre for Dermatology
 (1.9 away) Contact site
  • 861 views
  • 25 Jul, 2021
  • +87 other locations
None
Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT)

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of twice-daily (BID) oral difelikefalin (CR845) in adult subjects with notalgia paresthetica and moderate to severe pruritus.

Cara Therapeutics Study Site
 (0.0 away) Contact site
  • 0 views
  • 16 May, 2021
  • +20 other locations
None
Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation

The purpose of this study is to evaluate the safety and efficacy of trifarotene 50 microgram per gram (mcg/g) cream compared to its vehicle on the risk of formation of atrophic acne scars after 24 weeks of treatment in facial acne participants assessed by atrophic acne scars count.

Galderma Investigational Site #9918
 (0.0 away) Contact site
  • 1 views
  • 04 Aug, 2021
  • +17 other locations
None
Trial of PDE4 Inhibition With Roflumilast for the Management of Seborrheic Dermatitis (STRATUM)

The study will assess the safety and efficacy of ARQ-154 foam vs vehicle applied once for 8 weeks by subjects with seborrheic dermatitis.

erythema
Arcutis Biotherapeutics Clinical Site 32
 (1.9 away) Contact site
  • 12 views
  • 06 Oct, 2021
  • +49 other locations
None
Comprehensive Assessment of Neurodegeneration and Dementia

This is a 5-year observational study recruiting sixteen hundred and fifty individuals between the ages of 50 and 90 with different types of dementia as well as a comparison group of six hundred and fifty aged matched individuals without cognitive deficits. Participants will be recruited at sites across Canada and …

cognitive disorder
dementia
cognitive impairment
cognitive assessment
Kawartha Centre
 (0.2 away) Contact site
  • 314 views
  • 23 Jan, 2021
  • +33 other locations
None
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

TARGET-DERM is a 5-year, longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety …

atopy
skin disorder
dermatitis
mediators
skin disease
Skin Centre for Dermatology
 (1.8 away) Contact site
  • 3190 views
  • 10 Oct, 2021
  • +49 other locations